Viemed Healthcare Hits New 52-Week High of $10.46, Marking Strong Growth

Viemed Healthcare, Inc. has reached a significant milestone by hitting a new 52-week high of USD 10.46 on June 11, 2026. This achievement highlights the company's strong performance within the hospital industry, particularly as it operates within the microcap segment with a market capitalization of USD 357 million. Over the past year, Viemed Healthcare has demonstrated a notable performance, with a return of 22.78% compared to the S&P 500. The company's price-to-earnings (P/E) ratio stands at 22.00, indicating its valuation relative to earnings. Additionally, Viemed maintains a solid return on equity of 11.42%, reflecting its efficiency in generating profits from shareholders' equity. With no debt on its balance sheet and a price-to-book ratio of 2.52, Viemed Healthcare appears to be in a stable financial position. The stock's previous 52-week low was recorded at USD 5.93, marking a significant upward movement in its price trajectory. This recent high underscores the company's growth and resilience in the competitive healthcare market.